- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 29, 2025 | 60.39M sh |
| Long Term Debt | Q1 2025 · Dec 28, 2024 | $229.83M |
| Long Term Debt | Q1 2025 · Mar 30, 2024 | $233.05M |
| Stockholders Equity | Q1 2025 · Dec 28, 2024 | $3.22B |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $3.09B |
| Current Liabilities | Q1 2025 · Dec 28, 2024 | $512.45M |
| Current Liabilities | Q1 2025 · Mar 30, 2024 | $525.02M |
| Total Liabilities | Q1 2025 · Dec 28, 2024 | $900.95M |
| Total Liabilities | Q1 2025 · Mar 30, 2024 | $943.16M |
| Current Assets | Q1 2025 · Dec 28, 2024 | $2.5B |
| Current Assets | Q1 2025 · Mar 30, 2024 | $2.51B |
| Total Assets | Q1 2025 · Dec 28, 2024 | $4.15B |
| Total Assets | Q1 2025 · Mar 30, 2024 | $4.08B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 59.26M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $18.8M |
| Dividends Paid | Q1 2025 · Mar 30, 2024 | $20.41M |
| Capex | Q1 2025 · Mar 30, 2024 | $49.15M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | −$16.8M |
| Cash And Equivalents | Q1 2025 · Mar 30, 2024 | $979.75M |
| Cash And Equivalents restated | Q1 2025 · Dec 31, 2022 | $1.12B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $1.96 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $1.96 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $192.06M |
| Net Income | Q1 2025 · Mar 30, 2024 | $120.79M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $133.82M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $326.08M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $1.31B |